This biopharmaceutical company develops, manufactures, and markets both branded and generic prescription pharmaceuticals. They serve patients globally across regions like the EU and North America. Their product portfolio includes a range of dosage forms and focuses on key therapy areas such as endocrinology (as evidenced by their Cortrophin product). They prioritize quality assurance with GMP certifications and possess patents for some of their products, demonstrating innovation within their field.